Prime Medicine, Inc. (PRME)
3.835
0.00 (0.00%)
USD |
NASDAQ |
Nov 20, 10:11
Prime Medicine Cash from Investing (Quarterly) : 41.25M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 41.25M |
| June 30, 2026 | 24.03M |
| March 31, 2026 | 43.39M |
| December 31, 2025 | 28.33M |
| September 30, 2025 | -92.12M |
| June 30, 2025 | 2.771M |
| March 31, 2025 | -47.74M |
| December 31, 2024 | 48.25M |
| September 30, 2024 | 50.34M |
| June 30, 2024 | 6.894M |
| March 31, 2024 | -37.03M |
| December 31, 2023 | 41.28M |
| Date | Value |
|---|---|
| September 30, 2023 | -37.77M |
| June 30, 2023 | 27.86M |
| March 31, 2023 | -12.66M |
| December 31, 2022 | -13.69M |
| September 30, 2022 | -13.51M |
| June 30, 2022 | -50.79M |
| March 31, 2022 | 30.89M |
| December 31, 2021 | 12.15M |
| September 30, 2021 | -7.636M |
| June 30, 2021 | -77.17M |
| March 31, 2021 | -0.972M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 61.94M |
| Beam Therapeutics, Inc. | 101.86M |
| Twist Bioscience Corp. | -20.25M |
| Moderna, Inc. | -1.715B |
| Q32 Bio, Inc. | -0.052M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -36.68M |
| Cash from Financing (Quarterly) | 2.868M |
| Free Cash Flow | -158.54M |
| Free Cash Flow Per Share (Quarterly) | -0.2079 |
| Free Cash Flow to Equity (Quarterly) | -34.92M |
| Free Cash Flow to Firm (Quarterly) | -36.98M |
| Free Cash Flow Yield | -22.79% |